Overall Status

Completed (1,124)

Recruiting (188)

Unknown status (170)

Not yet recruiting (109)

Terminated (53)

Active, not recruiting (46)

Withdrawn (41)

Enrolling by invitation (21)

Suspended (2)

Phase

n/a (1,108)

phase 4 (125)

phase 3 (58)

phase 2 (34)

phase 1 (33)

phase 2/phase 3 (18)

phase 1/phase 2 (16)

early phase 1 (4)

Study Documents

Informed Consent Form (1)

Funder Type

Other (859)

Industry (826)

NIH (67)

U.S. Fed (2)

Study Type

Interventional (1,398)

Observational (332)

Observational [Patient Registry] (24)

scleral lens

Showing 1751 - 1754 of 1,754

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Macular Degeneration Trial run by the NEI (Celecoxib (Celebrex))

Completed

Macular Degeneration

Celecoxib (Celebrex)

Bethesda, Maryland

National Eye Institute (NEI)

Jul 18, 2006

The Results of Ahmed Valve Operations

Unknown status

Glaucoma

1) Intraocular pressure 2) visual acuity

Toronto, Ontario, Canada

Department of Ophthalmology and visual sciences, Toronto Western

Nov 29, 2005

Choroidal Neovascularization Trial in Stockholm (Photodynamic therapy versus Transpupillary thermotherapy)

Unknown status

Choroidal Neovascularization

Photodynamic therapy versus Transpupillary thermotherapy

Stockholm, Sweden

St Eriks Eye Hospital

Feb 2, 2006

Cataract, Uveitis Trial run by the National Eye Institute (NEI) (Heparin Surface-Modified Intraocular Lens)

Unknown status

Cataract
Uveitis

Heparin Surface-Modified Intraocular Lens

Bethesda, Maryland

National Institutes of Health

Jun 23, 2005